EMSCULPT NEO Technology Trains Astronauts for Space Missions

In a groundbreaking advancement for space exploration, BTL, a global leader in medical technology, proudly announces that its flagship product, the EMSCULPT NEO, has been integrated into astronaut training in Hungary. This innovative device is playing a vital role in preparing astronauts for their crucial missions, particularly in maximizing physical fitness for the challenges of space travel.

The partnership between BTL Hungary and the HUNOR program (Hungarian To Orbit) highlights the importance of advanced physical conditioning for astronauts. Tibor Kapu, a research astronaut from Hungary, is currently undergoing rigorous training with EMSCULPT NEO to prepare for his upcoming journey to the International Space Station (ISS). The necessity for such training is underscored by studies indicating that astronauts can lose up to 30% of their muscle mass during extended space missions.

According to Dr. Nóra Sydó, a leading cardiologist and sports medicine expert at Semmelweis University in Budapest, EMSCULPT NEO has been instrumental in enhancing both muscle performance and recovery. “This technology played a significant role in our rigorous pre-flight training protocol, enabling us to improve endurance, strength, and balance, while also facilitating quicker recovery,” said Dr. Sydó, who leads the astronaut training team.

EMSCULPT NEO is not just any fitness device. It employs a patented muscle stimulation technology that extends beyond traditional training methods. Through medical tests, it has demonstrated remarkable benefits such as muscle hypertrophy, better body composition, and enhanced cardiopulmonary fitness. Dr. Sydó also serves as the team doctor for Hungary’s Olympic swimming team, emphasizing the versatile applications of this technology in elite sports and rehabilitation.

Tomas Schwarz, CEO of BTL Enterprise Group, expressed pride in their involvement with astronaut training, stating, “This is a proud moment for us. Our aim is to enhance patient lives through innovation, and knowing that our technology supports individuals on a journey into space is a testament to the positive societal impact of our devices.”

The role of EMSCULPT NEO in astronaut training represents just one aspect of its remarkable capabilities. “Whether for an astronaut, an Olympic champion, or a patient suffering from muscle wasting, EMSCULPT NEO offers a non-invasive and effective supplemental solution to maintain and improve muscle function,” Dr. Sydó concluded, spotlighting the potential of this technology in both high-performance sports and everyday healthcare.

Founded in 1993, BTL is at the forefront of medical device innovation, providing cutting-edge solutions across diverse fields such as dermatology, plastic surgery, orthopedics, and rehabilitation, among others. With over 200 patents and a dedicated team of over 600 engineers, the company continues to leverage technology and science to advance medical treatments. Their product line includes EMSCULPT NEO®, EMFACE®, EXION®, EXOMIND™, EMSELLA®, among numerous other offerings.